Lisdexamfetamine, marketed as Vyvanse, is a scheduled drug recognized in Canada for addressing Attention-Deficit/Hyperactivity Disorder (ADHD) in individuals and adults . The medication functions as a https://sandoz-lisdexamfetamine-027809.gurusblogger.com/61951880/lisdexamfetamine-in-this-country-a-full-overview